Skip to main content
Log in

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

We had shown previously that progression of MOPC-315 plasmacytoma growth is associated with an increase in the percentage of macrophages in the spleen as well as a decrease in the ability of tumor-bearer spleen cells to mount an antitumor cytotoxic response upon in vitro immunization. Here we provide evidence that macrophages in the MOPC-315 tumor-bearer spleen are responsible at least in part for the suppression of the generation of antitumor cytotoxicity. Accordingly, removal of most macrophages by depletion of phagocytic cells or Sephadex G-10-adherent cells from spleens of mice bearing a large tumor resulted in augmented antitumor immune potential. Also, Sephadex G-10-adherent spleen cells from tumor-bearing (but not normal) mice drastically suppressed the in vitro generation of antitumor cytotoxicity by normal spleen cells. The suppressive activity of these adherent cells did not reside in contaminating suppressor T cells, since it was not reduced by treatment with monoclonal anti-Thy 1.2 antibody plus complement. The Sephadex G-10-adherent cell population from the tumor-bearer spleen suppressed the in vitro generation of antitumor cytotoxicity against autochthonous tumor cells but not against allogeneic EL4 tumor cells, and hence the suppression was apparently specific. The suppressive activity of the Sephadex G-10-adherent cell population from tumor-bearer spleens was overcome by treatment of the tumor-bearing mice with a low curative dose of cyclophosphamide. This immunomodulatory effect of a low dose of the drug in overcoming the suppression mediated by the Sephadex G-10-adherent cell population enables the effector arm of the immune system of tumor-bearing mice to cooperate effectively with the drug's tumoricidal activity in tumor eradication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baldwin RW, Price MR (1976) Tumor antigens and tumor-host relationships. Annu Rev Med 27:151

    Google Scholar 

  2. Bluestone JA, Lopez C (1979) Suppression of the immune response in tumor bearing mice. II. Characterization of adherent suppressor cells. J Natl Cancer Inst 63:1221

    Google Scholar 

  3. Braun DP, Harris JE (1981) Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients. J Natl Cancer Inst 67:809

    Google Scholar 

  4. Brunner KT, Mauel J, Rudolf H, Chapuis B (1970) Studies on autograft immunity in mice. I. Induction, development, and in vitro assay of cellular immunity. Immunology 18:499

    Google Scholar 

  5. Burton R, Thompson J, Warner NL (1975) In vitro induction of tumor-specific immunity. J Immunol Methods 8:133

    Google Scholar 

  6. Chang ZL, Wang J, Wang QD, Liu KL, Yao Z (1980) Activation of adherent suppressor macrophages in spleen of mice bearing Ehrlich solid tumor. Acta Biologiae Experimentalis Sinica 13:155

    Google Scholar 

  7. Dean JH, Cannon GB, Jerrells TR, McCoy JL, Herberman RB (1980) Sensitive parameters for general measurements of immunocompetence and antitumor reactivity in lung cancer patients and possible mechanisms of immunosuppression. In: Crispen RG (ed) Cancer immunotherapy: Experimental and clinical, vol 3. Elsevier/North-Holland, Amsterdam, p 357

    Google Scholar 

  8. Elgert KD, Farrar WL (1977) Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. J Immunol 120:1345

    Google Scholar 

  9. Fujimoto S, Greene MI, Sehon AH (1976) Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol 116:800

    Google Scholar 

  10. Garrigues HJ, Romero P, Hellstrom I, Hellstrom KE (1981) Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses. Cell Immunol 60:109

    Google Scholar 

  11. Glaser M, Kirchner H, Herberman RB (1975) Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors. Int J Cancer 16:384

    Google Scholar 

  12. Hellstrom KE, Hellstrom I (1974) Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol 18:209

    Google Scholar 

  13. Hellstrom KE, Hellstrom I, Nepom J (1977) Specific blocking factors: are they important? Biochim Biophys Acta 473:121

    Google Scholar 

  14. Hengst JCD, Mokyr MB, Dray S (1980) Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice. Cancer Res 40:2135

    Google Scholar 

  15. Hoover RG, Dieckgraefe BK, Lake J, Kemp JD, Lynch RG (1982) Lymphocyte surface membrane immunoglobulin in myeloma. III. IgA plasmacytomas induce large numbers of circulating, adult-thymectomy-sensitive, θ+, Lyt-1 2+ lymphocytes with IgA-Fc receptors. J Immunol 129:2329

    Google Scholar 

  16. Hoover RG, Gebel HM, Dieckgraefe BK, Hickman S, Rebbe NF, Hirayama N, Ovary Z, Lynch RG (1981) Occurrence and potential significance of increased numbers of T cells with Fc receptors in myeloma. Immunol Rev 56:115

    Google Scholar 

  17. Jerrells TR, Dean JH, Richardson GL, McCoy JL, Herberman RB (1978) Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 61:1001

    Google Scholar 

  18. Kenmarch J, Zolla-Pozner S (1980) Origin and function of suppressor macrophages in myeloma. J Immunol 124:268

    Google Scholar 

  19. Kirchner H, Chused TM, Herberman RB, Holden HT, Lavrin DH (1974) Evidence of suppressor cell activity in spleen of mice bearing primary tumors induced by moloney sarcoma virus. J Exp Med 139:1473

    Article  CAS  PubMed  Google Scholar 

  20. Koski IR, Poplack DG, Blaese RM (1977) A non-specific esterase stain for the identification of monocytes and macrophages. In: Bloom BR, David JR (eds) In vitro methods in cell-mediated tumor immunity. Academic Press, New York, p 359

    Google Scholar 

  21. Kruisbeek AM, Van Hees M (1977) Role of macrophages in the tumor-induced suppression of mitogen responses in rats. J Natl Cancer Inst 58:1653

    Google Scholar 

  22. Ledbetter JA, Herzenberg LA (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63

    Google Scholar 

  23. Ly IA, Mishell RI (1974) Separation of mouse spleen cells by passage through column of Sephadex G-10. J Immunol Methods 5:239

    Google Scholar 

  24. Mokyr MB, Braun DP, Dray S (1979) Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation. Cancer Res 39:785

    Google Scholar 

  25. Mokyr MB, Braun DP, Usher D, Reiter H, Dray S (1978) The development of in vitro and in vivo antitumor cytotoxicity in noncytotoxic, MOPC-315 tumor-bearer spleen cells ‘educated’ in vitro with MOPC-315 tumor cells. Cancer Immunol Immunother 4:143

    Google Scholar 

  26. Mokyr MB, Hengst JCD, Przepiorka D, Dray S (1979) Augmentation of antitumor cytotoxicity of MOPC-315 tumor-bearer spleen cells by depletion of dinitrophenol-adherent cells prior to in vitro immunization. Cancer Res 39:3928

    Google Scholar 

  27. Naor D (1979) Suppressor cells: Permitters and promoters of malignancy. Adv Cancer Res 29:45

    Google Scholar 

  28. Plata F, MacDonald HR, Shain B (1979) Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse. J Immunol 123:852

    Google Scholar 

  29. Rosenstreich DL, Blake JT, Rosenthal AS (1971) The peritoneal exudate lymphocyte I. Differences in antigen responsiveness between exudate and lymph node lymphocytes from immunized guinea pigs. J Exp Med 134:1170

    Google Scholar 

  30. Ting CC, Hargrove ME (1982) Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. J Natl Cancer Inst 69:873

    Google Scholar 

  31. Ting CC, Rodrigues D (1982) Tumor cell-triggered macrophage-mediated suppression and T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components of suppression. J Natl Cancer Inst 69:867

    Google Scholar 

  32. Tracey DE (1979) The requirement of macrophage in the augmentation of natural killer cell activity by BCG. J Immunol 123:840

    Google Scholar 

  33. Twomey JJ, Laughter AH, Farrow S, Douglas CD (1975) Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest 56:467

    Google Scholar 

  34. Webb PJ, Brooks CG, Baldwin RW (1980) Macrophage-like suppressor cells in rats. II. Evidence for a quantitative rather than a qualitative change in tumor-bearer animals. Cell Immunol 52:381

    Google Scholar 

  35. Webb DR, Nowowiejski I (1981) Control of suppressor cell activation via endogenous prostaglandin synthesis: The role of T cells and macrophages. Cell Immunol 63:321

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, QW., Mokyr, M.B., Pyle, J.M. et al. Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother 16, 162–169 (1984). https://doi.org/10.1007/BF00205423

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205423

Keywords

Navigation